Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -1.59 |
peg ratio | -0.02 |
price to book ratio | 9.16 |
price to sales ratio | 0.00 |
enterprise value multiple | -2.38 |
price fair value | 9.16 |
profitability ratios | |
---|---|
gross profit margin | 0.0% |
operating profit margin | 0.0% |
pretax profit margin | 0.0% |
net profit margin | 0.0% |
return on assets | -423.94% |
return on equity | -286.24% |
return on capital employed | -437.83% |
liquidity ratio | |
---|---|
current ratio | 3.68 |
quick ratio | 3.68 |
cash ratio | 3.54 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 0.00 |
days of payables outstanding | 23.74 |
cash conversion cycle | 0.00 |
receivables turnover | 0.00 |
payables turnover | 15.37 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.00 |
debt equity ratio | 0.00 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.00 |
interest coverage | -2.99 |
cash flow to debt ratio | 0.00 |
cash flow ratios | |
---|---|
free cash flow per share | -0.39 |
cash per share | 0.19 |
operating cash flow per share | -0.39 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | 0.00 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
MIRA Pharmaceuticals, Inc. (MIRA) published its most recent earnings results on 16-08-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA)'s trailing twelve months ROE is -286.24%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. MIRA Pharmaceuticals, Inc. (MIRA) currently has a ROA of -423.94%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
MIRA reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.68 in the most recent quarter. The quick ratio stood at 3.68, with a Debt/Eq ratio of 0.00.